SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neotherapuetics possibly has a breakthrough drug - NEOT -- Ignore unavailable to you. Want to Upgrade?


To: Marty who wrote (116)8/28/2000 3:45:59 PM
From: tuck  Respond to of 204
 
Hey, Marty,

Got lazy and didn't see this clue right away. However, nothing's been done yet, so I'm not going to beat myself up.

siliconinvestor.com

Per our public and private messages on this matter, this outlines the expected news flow very nicely. It goes into details of the breadth of their trials. The whole transaction makes more sense, because yeah, the burn rate is going up. If we are to bet that the news will be good, it would make sense for the bondholders to wait for this little rally to fade into October. Seasonally and technically probable. So I would expect to see something about resetting the conversion terms in about a month. If not, the bondholders are either legitimately backing NEOT, as you at first proposed, or have a longer time frame than I would have guessed. I still favor my convert soon scenario, because the low volume just doesn't give enough mileage/attention given for trading both sides of this transaction for years. I think they'll convert at least some shares this fall, whether they reset the terms or not.

So I'm expecting the stock to move back into the 6s, maybe even 5s again in a few weeks. At this point I'd expect conversion terms to be renegotiated. In any case, if it's in the above range in early October, I will buy a bit.

Cheers, Tuck